The Effect of Salpingectomy Operation on Ovarian Reserve
Evaluation of the Effect of Salpingectomy Operation on Ovarian Reserve With Anti-Mullerian Hormone and Ovarian Doppler Ultrasonography
1 other identifier
observational
31
1 country
1
Brief Summary
This study aimed to evaluate the effect of salpingectomy operation on ovarian reserve. Ovarian reserve was evaluated by measuring anti-mullerian hormone levels from serum samples taken from the patients before the operation and 6 weeks after the operation. Ovarian doppler flow were evaluated by measuring the ovarian artery pulsatility index with transvaginal ultrasonography preoperatively, postoperative days 2 and postoperative weeks 6 . In our study, it was determined that ovarian functions may be negatively affected in the acute period after salpingectomy operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2021
CompletedFirst Submitted
Initial submission to the registry
March 21, 2025
CompletedFirst Posted
Study publicly available on registry
March 31, 2025
CompletedApril 3, 2025
March 1, 2025
4 months
March 21, 2025
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
right ovarian arter pı
rate of 0,87/ 0,84/ 0,76
perioperative, postoperative days 2 , postoperative weeks 6
left ovarian arter pı
rate of 0,89/ 0,79/ 0.80
perioperative, postoperative days 2, postoperative weeks 6
AMH levels
Concentration of 1 ng/mL / 0,79 ng/mL
perioperative-postoperative weeks 6
Study Arms (3)
perioperative ovarian arter pulsatility index(PI)(right and left), perioperative AMH levels
postoperative days 2 ovarian arter pulsatility index (PI) (right and left)
postop. weeks 6 ovarian arter pulsatility index(PI)(right and left), postop. weeks 6 AMH levels
Interventions
The effect of salpingectomy operation on ovarian reserve
Eligibility Criteria
Serum samples will be separated from routine blood samples taken from patients who apply to the outpatient clinic and will undergo salpingectomy within the indication, during perioperative preparation and at the 6th week postoperatively, after patient consent is obtained. This serum sample will be taken into an Eppendorf tube and kept at -40˚C for later AMH levels to be studied. Ovarian artery pulsatility index values measured during the patient's perioperative and postoperative routine ultrasonographic examination and weeks 6 postoperative control will be recorded.
You may qualify if:
- Women between the ages of 37-45 with continuing menstrual cycles (37 and 45 included)
- Patients who will undergo uterine surgery for benign reasons or who will undergo salpingectomy only due to hydrosalpinx, ectopic pregnancy, tubo-ovarian abscess
- Patients who have not had ovarian surgery before
- Those without menopause and premature ovarian failure
- Patients who accept the study
You may not qualify if:
- Age younger than 37 or older than 45
- Those who want to withdraw from the study
- Those who do not come for follow-up examination
- Use of drugs that affect ovarian reserve
- Any surgical procedure performed on the ovaries during the operation
- No menstrual bleeding in the last year
- Patients who received radiotherapy and hormonal therapy within 3 months before surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylul University School of Medicine
Izmir, 35000, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 21, 2025
First Posted
March 31, 2025
Study Start
October 27, 2020
Primary Completion
March 3, 2021
Study Completion
June 5, 2021
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share